Skip to content

Pregabalin Effects on Hypotensive Anesthesia During Spine Surgery.

Pregabalin Effects on Hypotensive Anesthesia During Spine Surgery.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03301025
Enrollment
106
Registered
2017-10-04
Start date
2018-01-08
Completion date
2019-04-30
Last updated
2020-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spine Surgery

Keywords

Pregabalin, hypotensive anesthesia, blood loss, analgesia

Brief summary

Elective lumbar spine surgical procedures are commonly performed under controlled hypotension during general anesthesia. That is beneficial to limit the intraoperative blood loss and transfusions and improves surgical field. Deliberate hypotension could be achieved via various medications but mostly associated with significant side effects. Pregabalin effectively augmented hypotensive anesthesia. The hypothesis is that Pregabalin 150 mg single preoperative dose may augment intraoperative deliberate hypotension that will be reflected on blood loss and nitroglycerin consumption.

Detailed description

An arterial line will be established then general anesthesia will be conducted. After adequate preoxygenation, anesthesia induction by IV fentanyl 1.5µg/kg, propofol 2 mg/kg, and atracurium 0.5 mg/kg then appropriated size tracheal tube. The ventilator settings will be adjusted to maintain the end-tidal carbon dioxide tension (ETco2) at 30-35 mm Hg. Anesthesia will be maintained by isoflurane concentration 1.2%, with 40% oxygen in air then IV infusion of fentanyl 0.05 mcg/kg/min was started while atracurium 0.1 mg/kg incremental dose as required. Then patients will be turned into the prone position above pad support permitting free hanging of the abdomen. Intraoperatively, the target mean arterial arterial blood pressure (MBP) is 55-65 mm Hg. After surgical incision, if MBP exceeds 65 mm Hg (defined as hypertension) it will be managed by: increasing isoflurane MAC up to 2%, if no response after 5 min, Nitroglycerin infusion initiated at 0.5 mcg/kg/min to 40 mcg/kg/min. Hypotension (MBP \<55 mm Hg) will be treated by stopping nitroglycerin, proper compensation of losses, reducing Isoflurane MAC. If persisted; vasoactive drugs will be used. Bradycardia (HR \<50 beat/min.), treated with 0.01 mg/kg atropine IV increments. The nitroglycerin infusion will be stopped after the finial surgical hemostasis. Fentanyl infusion will be stopped before ligament sutures. Isoflurane will be closed after the last surgical suture. After dressing, patient will be turned to the supine position and morphine 0.025 mg/kg IV will be administered then 0.04 mg/kg neostigmine and 0.015 mg/kg atropine for reversal. Extubation will be done after establishment of acceptable spontaneous respiration.

Interventions

DRUGPregabalin

Pregabalin 150 mg capsule, one h preinduction of general anesthesia

DRUGplacebo

given a placebo identical capsule once one hour before anesthesia

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists (ASA) score I-II * admitted to undergo lumbar discectomy or spinal fixation surgery under general anesthesia

Exclusion criteria

* Patients on anti-hypertensive treatment, diuretics, corticosteroids, pregabalin, gabapentin, anticonvulsants, antipsychotics, * alcohol addiction or drug abuse * patients with history of allergy to any drug used in the study . * pregnant or nursing women * patients with peripheral neuropathy, endocrinal diseases, bleeding abnormality, * cardiac, hepatic or renal impairment

Design outcomes

Primary

MeasureTime frameDescription
Nitroglycerin consumptionIntraoperativethe total nitroglycerin consumption in milligram to maintain the target mean arterial pressure (MAP) 55- 65 mmHg.

Secondary

MeasureTime frameDescription
The number of transfused blood unitesintraoperativePacked red blood cell unites
heart rate (HR)Basal, during intubation, then at 1, 5, 30, 60, 90, 120, 150, 180, 210 minutes post extubation, then postoperatively at 1 and 2 hours.in beat/min
end-tidal isoflurane concentrationat 30, 60, 90, 120, 150 , 180, 210 minutes after intubation.in percent
Surgeon satisfaction about the fieldwithin 2 hours from the end of surgery.using a six-point scale (0 = no bleeding, virtually bloodless field; 5 = uncontrolled) bleeding).
Sedationat 0, 2, 4, 6, 12, 24 hours postoperatively(Ramsay sedation scale)
Estimated blood lossintraoperativetowels are weighted, plus suction volume without irrigation fluids in milliter.
Postoperative painat 0, 2, 4, 6, 12, 24 hours postoperatively.(VAS 0-10 scale) 10 is the worst pain
The total morphine consumptionin the 1st 24 hours postoperativelyin mg
Frequency of adverse effectsduring the first 24 hours postoperativelydizziness, headache, nausea and vomiting, or pruritus.
Peak airway pressures10 minutes after settled prone positionin centimeter water
invasive mean arterial blood pressure (MAP)Basal, during intubation, then at 1, 5, 30, 60, 90, 120, 150, 180, 210 minutes post extubation, then postoperatively at 1 and 2 hours.in millimeter mercury (mmHg)
The time to the first request of analgesia.24 hours postoperativein hours

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026